DOI:

Reliable angiographic evaluation by 64-slice computed tomography after trifurcation stenting of the left main coronary artery

Carlos A.G. Van Mieghem*, MD; Georgios Sianos, MD, PhD; Bob Meijboom, MD; Eleni Vourvouri, MD, PhD; Patrick W. Serruys, MD, PhD; Pim J. de Feyter, MD, PhD

A 39-year-old man underwent a complex percutaneous coronary intervention of the left main trifurcation due to unstable angina. Five paclitaxel-eluting stents were implanted successfully in the 3 major branches and left main trunk (Figure 1, panels A and B).

Figure 1. Two paclitaxel eluting stents (PES) were positioned simultaneously within the intermediate branch and circumflex artery (CX) together with balloon dilatation of the left anterior descending artery (LAD) to prevent plaque shift (panel A). The stent in the CX overlapped with a more distal stent in the same branch implanted at the start of the procedure. Due to dissection of the LAD ostium another PES was positioned in the proximal LAD and a fifth stent was deployed in the left main trunk (not shown). The procedure was completed with kissing balloon inflations of the 3 branches using 2 guiding catheters (one 5 and one 6 French guiding catheter), as indicated by the arrowhead and arrow (panel B). Invasive coronary angiography showed perfect patency of the 3 branches (panel C). Intravascular ultrasound confirmed the absence of neointimal hyperplasia, as shown by the IVUS cross-sectional image of the LMCA (panel D). b indicates balloon; CX, circumflex coronary artery; IB, intermediate branch; LAD, left anterior descending coronary artery; and s, stent.

Three months later follow-up 64-slice computed tomographic (MSCT) coronary angiography demonstrated excellent stent patency without signs of neointimal hyperplasia (Figure 2).

Figure 2. 64-slice CT coronary angiogram. Volume-rendered (panel A) and multiplanar reconstructed image (panel B) showing the stented left main trifurcation. The lumen within the stents is clearly visible along the 3 branches of the trifurcation (panels C, D and E). It is obvious that the 4 stents, including the stent edges, are perfectly patent without signs of neointima hyperplasia.

Ao indicates ascending aorta; CX, circumflex coronary artery; IB, intermediate branch; LAD, left anterior descending coronary artery; RVOT, right ventricular outflow tract.

Invasive coronary angiography and intravascular ultrasound (IVUS) confirmed these findings (Figure 1, panels C and D).

Current MSCT scanners provide a promising non-invasive alternative to conventional coronary angiography in the follow-up of patients after stenting of the left main coronary artery.

Volume 1 Number 4
Feb 20, 2006
Volume 1 Number 4
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00052 Nov 18, 2024
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off
Webb J and Offen S
free

Debate

10.4244/EIJ-E-24-00054 Nov 18, 2024
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons
Rodés-Cabau J et al
free

EAPCI Column

Nov 18, 2024
EAPCI at PCR London Valves 2024
free

Original Research

10.4244/EIJ-D-24-00442 Nov 18, 2024
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis
Cardaioli F et al

Original Research

10.4244/EIJ-D-24-00367 Nov 18, 2024
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study
Bieliauskas G et al
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved